Salix Announces 2022 Gastrointestinal Health Scholars Program Winners
For Third Consecutive Year, 10 Students with Gastrointestinal Disease Will
salix
Salix to Share New Data from XIFAXAN® (Rifaximin) Clinical Research at EASL’s International Liver Congress™ 2022
LAVAL, QC, June 20, 2022 — Bausch Health Companies Inc.
Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be
GrubMarket Expands Into South America through the Acquisition of Salix Fruits
GrubMarket acquires Salix Fruits, a global fresh fruit provider with
SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022
Featured Posters Will Include XIFAXAN® (rifaximin) and RELISTOR® (methylnaltrexone bromide)